• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Mapping human T cell epitopes on phospholipase A2: the major bee-venom allergen.

作者信息

Dhillon M, Roberts C, Nunn T, Kuo M

机构信息

Department of Medicine, Queen's University, Kingston, Ontario, Canada.

出版信息

J Allergy Clin Immunol. 1992 Jul;90(1):42-51. doi: 10.1016/s0091-6749(06)80009-6.

DOI:10.1016/s0091-6749(06)80009-6
PMID:1378459
Abstract

Phospholipase A2 (PLA2), the major bee-venom allergen, was purified by gel filtration, inactivated by denaturing, and carboxymethylating its cysteine residues. Peripheral blood mononuclear cells from an individual (HLA-DR2 [15], Dw52, DQ1 and DQ3) allergic to bee stings were used to generate cell lines specific for PLA2 and a control antigen, tetanus toxoid. These lines were 90% CD3+, 64% CD4+ and 20% CD8+ by fluorocytometry analysis. T-lymphocyte epitope mapping done with 12 overlapping synthetic peptides of PLA2 revealed two immunodominant epitopes. These epitopes correspond to amino acid sequences 50 to 69 and 83 to 97 of PLA2. Cytokine interleukin-4 and Interferon-gamma secretion was studied from PLA2- and tetanus toxoid-specific cell lines. Interleukin-4 secretion was common to both cell lines but only tetanus-toxoid cell lines secreted interferon-gamma. No interferon-gamma was found to be secreted by PLA2-specific cell line in response to stimulation by PLA2 or the two immunodominant peptides.

摘要

相似文献

1
Mapping human T cell epitopes on phospholipase A2: the major bee-venom allergen.
J Allergy Clin Immunol. 1992 Jul;90(1):42-51. doi: 10.1016/s0091-6749(06)80009-6.
2
Modulation of T-cell response to phospholipase A2 and phospholipase A2-derived peptides by conventional bee venom immunotherapy.传统蜂毒免疫疗法对T细胞对磷脂酶A2及磷脂酶A2衍生肽反应的调节作用。
J Allergy Clin Immunol. 1997 Jul;100(1):96-103. doi: 10.1016/s0091-6749(97)70200-8.
3
Delineation of PLA2 epitopes using short or long overlapping synthetic peptides: interest for specific immunotherapy.使用短或长的重叠合成肽描绘磷脂酶A2表位:对特异性免疫疗法的意义
Clin Exp Allergy. 1997 Sep;27(9):1016-26. doi: 10.1111/j.1365-2222.1997.tb01253.x.
4
Allergen dose dependent cytokine production regulates specific IgE and IgG antibody production.变应原剂量依赖性细胞因子产生调节特异性IgE和IgG抗体产生。
Adv Exp Med Biol. 1996;409:295-303. doi: 10.1007/978-1-4615-5855-2_42.
5
To bee or not to be? T-cell responses to bee venom PLA2 in relation to anaphylaxis and immunotherapy.是或不是?T细胞对蜂毒磷脂酶A2的反应与过敏反应和免疫治疗的关系。
Clin Exp Allergy. 1997 Sep;27(9):986-90. doi: 10.1111/j.1365-2222.1997.tb01245.x.
6
Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom.用蜂毒磷脂酶A2的T细胞表位肽进行成功的免疫疗法可诱导对蜂毒过敏患者的特异性T细胞无反应性。
J Allergy Clin Immunol. 1998 Jun;101(6 Pt 1):747-54. doi: 10.1016/S0091-6749(98)70402-6.
7
Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.蜂毒免疫疗法中针对磷脂酶A2的表位特异性T细胞耐受性及IL-2和IL-15在体外的恢复作用
J Clin Invest. 1996 Oct 1;98(7):1676-83. doi: 10.1172/JCI118963.
8
Bee venom phospholipase A2-specific T cell clones from human allergic and non-allergic individuals: cytokine patterns change in response to the antigen concentration.来自人类过敏和非过敏个体的蜂毒磷脂酶A2特异性T细胞克隆:细胞因子模式随抗原浓度变化。
Eur J Immunol. 1992 Jun;22(6):1357-63. doi: 10.1002/eji.1830220605.
9
Efficacy of a therapeutic treatment using gas-filled microbubble-associated phospholipase A2 in a mouse model of honeybee venom allergy.气体填充微泡相关磷脂酶 A2治疗方案在蜜蜂毒液过敏小鼠模型中的疗效。
Allergy. 2016 Jul;71(7):957-66. doi: 10.1111/all.12859. Epub 2016 Mar 2.
10
Determinants and mechanisms of human immune responses to bee venom phospholipase A2.人类对蜂毒磷脂酶A2免疫反应的决定因素及机制
Int Arch Allergy Immunol. 1998 Sep;117(1):1-10. doi: 10.1159/000023984.

引用本文的文献

1
Bee Venom Immunotherapy: Current Status and Future Directions.蜂毒液免疫治疗:现状与未来方向。
Clin Rev Allergy Immunol. 2020 Jun;58(3):326-341. doi: 10.1007/s12016-019-08752-x.
2
Therapeutic Properties of Bioactive Compounds from Different Honeybee Products.不同蜂产品中生物活性化合物的治疗特性。
Front Pharmacol. 2017 Jun 28;8:412. doi: 10.3389/fphar.2017.00412. eCollection 2017.
3
Effect of Bee Venom and Its Fractions on the Release of Pro-Inflammatory Cytokines in PMA-Differentiated U937 Cells Co-Stimulated with LPS.
蜂毒及其组分对 PMA 分化的 U937 细胞与 LPS 共刺激后促炎细胞因子释放的影响。
Vaccines (Basel). 2016 Apr 19;4(2):11. doi: 10.3390/vaccines4020011.
4
Hymenoptera venom allergens.膜翅目昆虫毒液过敏原
Clin Rev Allergy Immunol. 2006 Apr;30(2):109-28. doi: 10.1385/criai:30:2:109.
5
Identification of antigenic epitopes on human allergens: studies with HLA transgenic mice.人类过敏原上抗原表位的鉴定:对 HLA 转基因小鼠的研究
Environ Health Perspect. 2003 Feb;111(2):245-50. doi: 10.1289/ehp.5706.
6
Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy.主要桦树花粉过敏原Bet v 1亚型的免疫球蛋白E和T淋巴细胞反应性剖析:低变应原性亚型在免疫治疗中的潜在应用
J Exp Med. 1996 Feb 1;183(2):599-609. doi: 10.1084/jem.183.2.599.
7
Novel approaches in immunotherapy.免疫疗法中的新方法。
Clin Rev Allergy. 1994 Spring;12(1):23-42. doi: 10.1007/BF02815508.